You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Intratumoral (IT)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in New York (Intratumoral (IT) Poly ICLC 0.5 mg, Intratumoral (IT) Poly ICLC 1.0 mg, Intramuscular (IM)

Completed
  • Prostate Cancer
  • Intratumoral (IT) Poly ICLC 0.5 mg
  • +3 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Sep 8, 2022

Solid Tumor, Lymphoma Trial in Israel, United States (MK-2118 (IT), MK-2118 (SC), Pembrolizumab)

Completed
  • Solid Tumor
  • Lymphoma
  • MK-2118 (IT)
  • +2 more
  • La Jolla, California
  • +7 more
Jan 23, 2023

Melanoma Trial in Madison (hu14.18-IL2, Radiation Therapy, Nivolumab)

Suspended
  • Melanoma
  • hu14.18-IL2
  • +3 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Jan 3, 2022

Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Worldwide (Ulevostinag, Pembrolizumab)

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma (HNSCC)
  • Los Angeles, California
  • +33 more
Oct 4, 2021

Cancer, Melanoma Stage III, Melanoma Stage IV Trial (KB707)

Not yet recruiting
  • Cancer
  • +6 more
  • KB707
  • (no location specified)
Jul 24, 2023

Gastric Adenocarcinoma Trial in Pessac (Gastrectomy)

Recruiting
  • Gastric Adenocarcinoma
  • Gastrectomy
  • Pessac, France
    Hôpital du Haut Lévêque
Mar 23, 2023

Advanced Solid Tumor, Sarcoma, HNSCC Trial in China (T3011)

Recruiting
  • Advanced Solid Tumor
  • +6 more
  • T3011
  • Hefei, Anhui, China
  • +18 more
Oct 30, 2022

Squamous Cell Carcinoma of the Skin, Malignant Melanoma of Skin, Merkel Cell Carcinoma of Skin Trial in Marlborough (PH-762)

Not yet recruiting
  • Squamous Cell Carcinoma of the Skin
  • +2 more
  • Marlborough, Massachusetts
    Phio Pharmaceuticals Corp.
Aug 25, 2023

Cutaneous Tumor, Malignant Solid Tumor Trial (JCXH-211 Injection)

Not yet recruiting
  • Cutaneous Tumor
  • Malignant Solid Tumor
  • JCXH-211 Injection
  • (no location specified)
Feb 13, 2023

Squamous Cell Carcinoma, RP1 Trial (RP1)

Not yet recruiting
  • Squamous Cell Carcinoma
  • RP1
  • (no location specified)
May 4, 2023

Colorectal Cancer Trial in Køge (Influenza Vaccines)

Completed
  • Colorectal Cancer
  • Influenza Vaccines
  • Køge, Zealand, Denmark
    Zealand University Hospital
Dec 12, 2022

Sarcoma Trial in Beijing (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))

Recruiting
  • Sarcoma
  • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)
  • Beijing, China
    Peking University People's Hospital
Nov 6, 2023

Solid Tumor Trial in Guangzhou (CAN1012)

Recruiting
  • Solid Tumor
  • Guangzhou, Guangdong, China
    Canwell Biotech Limited
Oct 13, 2022

Using Deep Learning and Radiomics to Diagnose Benign and

Completed
  • Breast Diseases
    • Jinan, Shandong, China
      QianfoshanH
    Sep 29, 2023

    Squamous Cell Carcinoma of Head and Neck Trial in United States (CMP-001, Pembrolizumab)

    Active, not recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Little Rock, Arkansas
    • +18 more
    Aug 1, 2022

    Advanced Melanoma Trial in New York, Houston (LTX-315 in combination with pembrolizumab)

    Recruiting
    • Advanced Melanoma
    • LTX-315 in combination with pembrolizumab
    • New York, New York
    • +7 more
    Jan 23, 2023

    Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • +13 more
    • (no location specified)
    Aug 29, 2023

    Cutaneous Tumor, Malignant Solid Tumor Trial in Houston (JCXH-211)

    Not yet recruiting
    • Cutaneous Tumor
    • Malignant Solid Tumor
    • Houston, Texas
      The University of Texas MD Anderson Cancer Center
    Sep 9, 2022

    Advanced Solid Tumor, Lung Cancer, Pancreas Cancer Trial in Chengdu (CNSI-Fe(II) 30 mg, CNSI-Fe(II) 60 mg, CNSI-Fe(II) 90 mg)

    Recruiting
    • Advanced Solid Tumor
    • +8 more
    • CNSI-Fe(II) 30 mg
    • +2 more
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    Sep 15, 2023

    Non Small Cell Lung Cancer, Solid Tumor Trial in Jette, Brussel (Avelumab, Ipilimumab 5 MG/ML, Pembrolizumab 100 MG in 4 ML

    Recruiting
    • Non Small Cell Lung Cancer
    • Solid Tumor
    • Jette, Brussels, Belgium
    • +1 more
    Sep 9, 2022

    Metastatic Lung Cancer, Metastatic Breast Cancer, Metastatic Gastric Cancer Trial in Rotterdam (Tusamitamab ravtansine)

    Not yet recruiting
    • Metastatic Lung Cancer
    • +2 more
    • Tusamitamab ravtansine
    • Rotterdam, Netherlands
      Erasmus MC
    Jan 26, 2023

    Metastatic Prostatic Adenocarcinoma Trial in Lancaster, Rochester (Opdivo Injectable Product, Yervoy Injectable Product,

    Completed
    • Metastatic Prostatic Adenocarcinoma
    • Opdivo Injectable Product
    • +3 more
    • Lancaster, California
    • +1 more
    Jun 15, 2022

    ER-Negative PR-Negative HER2-Negative Breast Cancer Trial in Stanford (IT-pIL12-EP)

    Completed
    • ER-Negative PR-Negative HER2-Negative Breast Cancer
    • IT-pIL12-EP
    • Stanford, California
      Stanford University
    Jul 15, 2019

    Advanced Solid Tumor Trial (SGN1)

    Not yet recruiting
    • Advanced Solid Tumor
    • (no location specified)
    Jan 30, 2023

    NSCLC Trial in Burlington (cis-diamminedichloroplatinum)

    Recruiting
    • Non-Small Cell Lung Cancer
    • Burlington, Vermont
      University of Vermont
    May 20, 2022